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Macroautophagy is thought to protect against
apoptosis; however, underlying mechanisms are
poorly understood. We examined how autophagy
affects canonical death receptor-induced mitochon-
drial outer membrane permeabilization (MOMP) and
apoptosis. MOMP occurs at variable times in a pop-
ulation of cells, and this is delayed by autophagy.
Additionally, autophagy leads to inefficient MOMP,
after which some cells die through a slower process
than typical apoptosis and, surprisingly, can recover
and divide afterward. These effects are associated
with p62/SQSTM1-dependent selective autophagy
causing PUMA levels to be kept low through an
indirect mechanism whereby autophagy affects
constitutive levels of PUMA mRNA. PUMA depletion
is sufficient to prevent the sensitization to apoptosis
that occurs when autophagy is blocked. Autophagy
can therefore control apoptosis via a key regulator
that makes MOMP faster and more efficient, thus
ensuring rapid completion of apoptosis. This iden-
tifies a molecular mechanism whereby cell-fate deci-
sions can be determined by autophagy.
INTRODUCTION
Macroautophagy and apoptosis are closely linked (Gump and
Thorburn, 2011; Maiuri et al., 2007b; Rubinstein and Kimchi,
2012). Molecular mechanisms whereby autophagy can promote
apoptosis in response to specific stimuli have been identified in
Drosophila (Nezis et al., 2010) and, more recently, in mammalian
cells (Gump et al., 2014). However, because autophagy is pri-
marily a prosurvival mechanism, it is generally thought that the
two processes regulate each other in opposite directions.
Distinct molecular mechanisms have been identified whereby
apoptosis can inhibit autophagy. For example, caspases cleaveautophagy regulators such as Beclin 1 (BECN1) to suppress
autophagy (Cho et al., 2009; Li et al., 2011; Luo and Rubinsztein,
2010). In contrast, mechanisms by which autophagy protects
against apoptosis are poorly understood. The simplest way
that autophagy can protect against apoptosis is by modulating
the stresses that activate the apoptosis machinery. For example,
autophagy protects against nutrient and growth-factor-depriva-
tion-induced apoptosis (Boya et al., 2005; Lum et al., 2005).
However, this need not mean that autophagy inhibits the core
apoptosis machinery; instead, degradation of cellular compo-
nents by autophagy can supply macromolecular precursors
and energy until nutrients are restored, and this might avoid
activation of apoptosis signaling at all. Although many proteins
regulate both autophagy and apoptosis (Gump and Thorburn,
2011; Rubinstein and Kimchi, 2012), general mechanisms by
which the process of autophagy controls the core apoptosis
machinery have not been identified. Nevertheless, because
diverse apoptotic stimuli (e.g., different classes of chemotherapy
drugs; Levy and Thorburn, 2011) can all be sensitizedwhen auto-
phagy is inhibited, it is widely suggested that regulation of the
core apoptosis machinery by autophagy must exist.
Even when cells in a clonal population die in response to a
defined stimulus, there is considerable variation in the timing of
apoptosis (Albeck et al., 2008; Goldstein et al., 2000; Spencer
et al., 2009). Single-cell imaging of well-understood apoptosis
stimuli such as the Tumor Necrosis Factor-Related Apoptosis
Inducing Ligand (TRAIL) have shown how this cell-to-cell varia-
tion comes about. TRAIL induces apoptosis in most cells via
‘‘Type II apoptosis’’ whereby TRAIL receptor signaling leads to
activation of caspase-8, which cleaves the BH3 domain-contain-
ing protein BID to create a truncated protein called tBID. tBID
translocates to mitochondria causing BAX- and BAK-dependent
permeabilization of the outer mitochondrial membrane releasing
cytochrome c, Smac/Diablo, and other mitochondrial proteins.
Mitochondrial Outer Membrane Permeabilization (MOMP) is
completed within a few minutes (Goldstein et al., 2000; Rehm
et al., 2003) and is widely considered a point of no return that
marks commitment to death because it is followed within
5–10min by a burst of effector caspase activity that causes rapidCell Reports 7, 45–52, April 10, 2014 ª2014 The Authors 45
contraction and fragmentation of the cell. The variation in timing
of apoptosis is due to variation in the time when MOMP occurs
and has been extensively studied in TRAIL-treated HeLa cells
(Albeck et al., 2008; Spencer et al., 2009).
Here, we examined the effects of autophagy on this well-
understood canonical apoptosis pathway. We found that auto-
phagy controls the core apoptosis machinery by regulating the
timing of MOMP and the cell response after MOMP. These
effects can be explained by autophagy’s ability to regulate low
constitutive levels of the BH3 domain-containing protein
PUMA. Surprisingly, autophagy’s effects on PUMA can also
lead to slow and incomplete cellular degradation after MOMP
from which some cells can recover and go on to divide and the
proapoptotic effect of autophagy inhibition on viability of cells
after apoptosis stimulation is blocked by removal of PUMA.
This defines a mechanism by which autophagy can control the
apoptotic threshold to govern cell fate.
RESULTS AND DISCUSSION
Timing of MOMP Is Regulated by Autophagy
We treated HeLa cells with TRAIL and monitored MOMP using
time-lapse microscopy to determine when a mitochondrial-tar-
geted Red Fluorescent Protein (Albeck et al., 2008) was released
into the cytoplasm. Autophagy was increased by treatment with
trehalose, which activates autophagy via anmTOR-independent
mechanism (Sarkar et al., 2007) and, unlike other autophagy
stimulators like mTOR inhibitors or starvation, has no known
other effects on cell viability. Autophagy was inhibited by RNAi
knockdown of essential autophagy regulators such as ATG12
as shown by reduced accumulation of LC3-II in cells where
autophagic flux was blocked (Figure 1A). As expected (Albeck
et al., 2008), MOMP was completed within 5 min (Figure 1B)
starting at variable times (Figure 1C) from approximately
50 min to over 2 hr following treatment with TRAIL at doses suf-
ficient to induce MOMP in all the cells in the population. Treha-
lose-treated cells still underwent MOMP; however, its timing
was markedly delayed when autophagy was stimulated. This
delay was blocked when autophagy was inhibited by knock-
down of ATG12 (Figure 1C) indicating that, although trehalose
has other properties that stabilize proteins and organelles (Jain
and Roy, 2009), the effects we see here were due to increased
autophagy. Delayed MOMP was also prevented when other
autophagy regulators (ATG7, ATG5, and BECN1) were knocked
down (Figures S1A–S1C) indicating that this is an autophagy-
dependent effect and not other functions of the targeted genes.
Increased autophagy might delay MOMP by inhibiting sig-
naling at the TRAIL receptor. Indeed, it has been reported that
autophagy can degrade activated caspase-8 (Hou et al., 2010).
Trehalose did not noticeably reduce or slow TRAIL-induced
caspase-8 or BID cleavage (Figure 1D). This suggests that auto-
phagy does not delay MOMP by altering the initial steps in TRAIL
receptor signaling. To test this, wemonitored the effects of auto-
phagy induction on MOMP induced by Fas Ligand or an artifi-
cially dimerized caspase-8 molecule (Oberst et al., 2010), which
both also showed autophagy-dependent delay (Figures S1D and
S1E). The lack of delay in BID cleavage and similar delay in
MOMP after activation of caspase-8 by other stimuli or even arti-46 Cell Reports 7, 45–52, April 10, 2014 ª2014 The Authorsficial dimerization suggests that autophagy’s ability to delay
MOMP is due to an effect on mitochondrial permeabilization by
tBID rather than an effect on signaling at the TRAIL receptor
itself.
Autophagy Regulates PUMA Levels to Control Timing
of MOMP
To test mechanisms at the mitochondria, we asked if BH3-
domain proteins were altered when autophagy was inhibited.
Inhibition of autophagy by knockdown of ATG5, ATG7, ATG12,
Vps34/PIK3C3, or the selective autophagy mediator p62/
SQSTM1 (Johansen and Lamark, 2011; Noda et al., 2010) all
caused an increase in PUMA levels (Figure 1E). PUMA increase
following ATG knockdown was seen in a variety of tumor cell
lines of different tissue origin in addition to HeLa cells (Fig-
ure S2A) including thosewith wild-type ormutant p53. This effect
was selective and other BH3 proteins (e.g., BAD, BIM, and
NOXA) showed no increase when autophagy was blocked (Fig-
ure S2C). PUMA protein levels might increase after ATG gene
knockdown because autophagy directly degrades PUMA or
because autophagy degrades something else that inhibits
PUMA expression. We examined PUMA mRNA and found that
knockdown of essential autophagy regulators and p62/SQSTM1
could increase PUMA mRNA levels suggesting that an indirect
mechanism applies. These effects were seen in HeLa cells,
which have low levels of p53 and in MDA MB 231 cells (Fig-
ure S2B), which have mutant p53. These data suggest that the
mechanism is due to modulation of constitutive PUMA expres-
sion not through induced PUMA transcription as occurs in
response to p53 activators. Because efficient MOMP requires
that proteins like tBID cooperate with PUMA (Chipuk et al.,
2008; Chipuk and Green, 2009), we next determined the effect
of PUMA knockdown on the timing of MOMP after TRAIL treat-
ment. PUMA small hairpin RNA (shRNA) was sufficient to delay
MOMP similarly to that seen with trehalose treatment, and this
delay was not extended if the PUMA knockdown cells were
also treated with trehalose (Figure 1F).
Higher Autophagy and PUMA Degradation Allows
Cellular Recovery after MOMP
Cell contraction and breakup usually occurs in less than 5 min
after MOMP has taken place (Albeck et al., 2008). Consistent
with this, control cells where no autophagy manipulation was
applied usually contracted quickly after MOMP so that within
20 min the vast majority of cells had a surface area less than
60% of their area immediately before MOMP. However, some
cells contract more slowly, and, when autophagy was stimulated
with trehalose, it wasmore common for dying cells to take longer
to contract after MOMP as measured by this metric (Figure 2A).
This effect was reversed by knockdown of ATG5 or ATG7 (Fig-
ure 2B) indicating that these effects were also autophagy depen-
dent. Surprisingly, continued imaging showed that, although, as
expected, most cells underwent MOMP, fast contraction, and
then death (Figure 2C), cells undergoing slow contraction after
MOMP could sometimes recover and display a normal
morphology (Figure 2D). To test if these effects were due to
autophagy’s ability to degrade PUMA, we assessed ‘‘slow’’
death in PUMA knockdown cells. Figure 3A shows that PUMA
Figure 1. Autophagy Regulates the Timing of MOMP and PUMA Levels
(A) siRNA targeting ATG12 in HeLa cells inhibits trehalose-induced (Tre) autophagy shown by reduced accumulation of LC3-II after treatment with lysosomal
protease inhibitors Pepstatin and E64D.
(B) An example of complete and rapid MOMP visualized in HeLa cells stably expressing IMS-RP. Loss of punctate IMS-RP staining was used to determine when
MOMP took place after TRAIL treatment.
(C) Trehalose treatment delays MOMP after TRAIL treatment (25 ng/ml), and this delay is blocked by autophagy inhibition using ATG12 siRNA. Cells were imaged
individually after treatment with or without trehalose and siRNA as indicated. Bars indicate the mean time to MOMP, p values by Student’s t test.
(D) Western blot analysis of time course of TRAIL-treated HeLa cells without or with trehalose to analyze cleavage of initiator caspase-8 or BID. Autophagy
induction by trehalose did not delay caspase-8 or Bid cleavage.
(E) Autophagy inhibition by shRNA knockdown of ATG5, ATG7, ATG12, Vps34, or p62/SQSTM1 all cause an increase in PUMA levels.
(F) PUMA knockdown is sufficient to delay MOMP in response to TRAIL treatment. Cells were infected with shRNA targeting PUMA in the presence or absence of
trehalose as indicated and time toMOMPdetermined by imaging individual cells. PUMA knockdown is sufficient delayMOMP similarly to trehalose. Bars indicate
mean time to MOMP, p values were calculated by t test, and ns indicates p > 0.05.
See also Figures S1 and S2.
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Figure 2. Autophagy Is Associated with Slow Cellular Contraction after MOMP and Cellular Recovery
(A) Images from time-lapse series showing cellular contraction after MOMP displaying two distinct phenotypes. An example of rapid contraction and cellular
breakup is shown in the upper series of images. An example of slower contraction after MOMP.
(legend continued on next page)
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Figure 3. PUMA Depletion Is Sufficient to Increase the Likelihood of Slow Cellular Contraction and Cell Recovery and Can Allow Division
after MOMP
(A) Quantitation of cell area 20min after MOMP in cells treated with trehalose in the presence or absence of PUMA knockdown. The percentage of cells displaying
slow contraction is increased by PUMA knockdown alone.
(B) PUMA knockdown cells displaying slow contraction and recovery can go on to divide. Images from a time-lapse experiment showing two cells that underwent
MOMP followed by slow contraction, recovery of normal morphology, and then cell division. Scale bars, 40 mm.
See also Movies S1 and S2.knockdown alone, like autophagy induction, increases the num-
ber of cells displaying slow contraction after incomplete MOMP.
Moreover, continued monitoring demonstrated that these cells
(in the absence of any artificial caspase inhibition) could recover
normal morphology and even divide afterward (Figure 3B;
Movies S1 and S2).
The previous experiments were performed with doses of
TRAIL high enough to ensure that MOMP eventually occurred
in all or almost all the cells. However, if these mechanisms affect
the long-term viability of cells, they would be expected to mani-(B) Quantification of the percent of cells displaying slow contraction after MOMP
MOMP. Cells were treated with trehalose in the presence or absence of ATG5 or A
cells, and this is abolished by autophagy inhibition.
(C) Continued monitoring of fast contracting cells after MOMP shows irreversible
(D) Continued monitoring of slow contracting cells shows that they can recover nfest as modulation of the response to different doses of TRAIL.
Therefore, we continuously monitored long-term survival in
mixed populations of isogenic HeLa cells with specific knock-
downs that were marked with GFP-NLS or Cherry-NLS tags
and treated with different doses of TRAIL. As expected, knock-
down of BID completely prevented TRAIL-induced apoptosis
(Figure 4A). PUMA knockdown did not prevent apoptosis but
did reduce its efficiency as shown by consistent increased
viability at different doses of TRAIL (Figure 4B). This effect was
selective for PUMA because knockdown of another BH3 proteindefined as cell areaR60% of the original area 20 min after MOMP/incomplete
TG7 shRNAs as indicated. Trehalose increases the number of slow contracting
cell breakup and death from which they cannot recover.
ormal morphology hours after MOMP. Scale bars, 40 mm.
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Figure 4. Autophagy Regulation of Long-Term Cell Viability after TRAIL-Induced Apoptosis Is Explained by Regulation of PUMA
(A) Quantitation of cell viability by continuous monitoring of mixed populations of control (green) or shRNA knockdown (red) cells. HeLa cells were marked with
nuclear GFP or mCherry, and cell viability after treatment with different doses of TRAIL was determined by continual monitoring using the IncuCyte system.
shRNA knockdown of BID completely protects against TRAIL-induced death.
(B) shRNA knockdown of PUMA partially inhibits TRAIL-induced apoptosis.
(C) shRNA knockdown of ATG7 to inhibit autophagy potentiates TRAIL-induced apoptosis.
(D) shRNA knockdown of Vps34 to inhibit autophagy potentiates TRAIL-induced apoptosis.
(E) Cell viability quantified by the IncuCyte at different doses of TRAIL was determined in matched control, ATG7, or ATG7/PUMA knockdown cells. Autophagy
inhibition by ATG7 knockdown increases TRAIL-induced apoptosis, and this is rescued by simultaneous knockdown of PUMA. At higher doses of TRAIL, the
protective effect of autophagy inhibition is reduced.
(F) Cell viability quantified by the IncuCyte in matched control, ATG12, or ATG12/PUMA knockdown cells. Autophagy inhibition by ATG12 knockdown increases
TRAIL-induced apoptosis that is rescued by simultaneous knockdown of PUMA. Error bars represent SD.
See also Figures S3 and S4.(NOXA) did not affect cell viability (Figure S3). Inhibition of auto-
phagy by knockdown of ATG7 (Figure 4C) or Vps34/PIK3C3 (Fig-
ure 4D) had the opposite effect as knockdown of PUMA and
sensitized to apoptosis indicating a protective effect of auto-
phagy. Importantly, autophagy’s protective effect as shown by
sensitization to apoptosis upon knockdown of ATG7 (Figure 4E)50 Cell Reports 7, 45–52, April 10, 2014 ª2014 The Authorsor ATG12 (Figure 4F) was abolished by PUMA knockdown.
Consistent with a modulatory role, protection against potentia-
tion by autophagy inhibition by PUMA depletion was less
pronounced when higher doses of TRAIL were used. Thus,
TRAIL-induced apoptosis is, as expected, completely depen-
dent on BID, but the efficiency of BID-induced MOMP and
subsequent apoptosis are modulated by PUMA. Additionally,
the ability of autophagy to selectively regulate PUMA levels ex-
plains how autophagy protects against apoptosis and modu-
lates the apoptotic threshold. This effect also occurred in
TRAIL-treated MDA MB 231 cells (Figure S4C). PUMA knock-
down also partially rescued from the potentiation of death
induced by autophagy inhibition in response to the general
apoptosis inducer staurosporine in both HeLa (Figures S4A
and S4B) and MDA MB 231 cells (Figure S4C). These data sug-
gest that this mechanism applies generally during canonical
mitochondrial apoptosis but that when stimuli, such as stauro-
sporine, that are not pure apoptosis inducers like TRAIL are
used, protection by PUMA knockdown is reduced.
BCL-family proteins stimulate or inhibit autophagy and
apoptosis, and these activities are at the center of the mutual
regulation of these two processes by each other. For example,
antiapoptotic BCL family proteins like BCL-2 and BCL-xL
inhibit autophagy (Pattingre et al., 2005). BH3-only proteins
such as BAD (Maiuri et al., 2007a), NOXA (Elgendy et al.,
2011), or PUMA (Zhang et al., 2012) can activate autophagy,
whereas others such as BIM inhibit autophagy (Luo et al.,
2012) showing that autophagy is both positively and negatively
regulated by proapoptotic BH3 proteins. PUMA has been re-
ported to regulate mitophagy through a Bax-dependent mech-
anism (Yee et al., 2009); this activity is different from that
observed here because it appears to promote rather than
inhibit apoptosis. Our results expand this picture by showing
that autophagy regulates BH3 protein function in canonical
apoptosis through a p62-dependent mechanism that selec-
tively and likely indirectly controls PUMA levels. It is known
that PUMA can synergize with activator BH3 proteins such as
BID to promote rapid and efficient MOMP followed quickly by
complete apoptosis (Chipuk et al., 2008; Chipuk and Green,
2009). We propose that this mechanism is exploited to allow
autophagy to inhibit apoptosis. Constitutive PUMA expression
is kept low by selective autophagy through an indirect mecha-
nism, which ultimately affects PUMA mRNA, and this allows
changes in PUMA levels to regulate the kinetics and efficiency
of MOMP. This mechanism provides a way for autophagy to
modulate the rate-limiting step in apoptosis. Moreover, when
MOMP does happen in cells with low PUMA, the process is
inefficient, and cells are more likely to undergo a slow contrac-
tion following caspase activation that is different from that seen
in the majority of cells where MOMP is rapidly followed by com-
plete apoptosis and breakup of the cell. Surprisingly, some of
these slow cells can recover and even go on to divide. This
identifies a mechanism by which autophagy can directly control
the core apoptosis machinery and suggests that autophagy’s
ability to regulate PUMA levels controls synergy with MOMP
activators like BID to regulate the apoptotic threshold that de-
termines cell fate.EXPERIMENTAL PROCEDURES
Cell Culture and Reagents
Tumor cell lines cells were cultured in media recommended by ATCC and
maintained at 37C, 5% CO2. hTRAIL/TNFSF10 was obtained from R&D
Systems and used at a final concentration of 25 ng/ml or as indicated.Leucine-zipper-tagged FasL construct was expressed in mammalian cells
for the production of soluble active oligomerized FasL. Trehalose was ob-
tained from Sigma and used at a final concentration of 75 mM.
Western Blotting and Antibodies
Proteins were separated by SDS-PAGE and transferred onto either nitrocellu-
lose or PVDF membranes. Blots were probed with antibodies that recognize
ATG5, ATG7, ATG12, BECN-1, BAD, BID, BIM, CASP 3, CASP 8, PI3K Class
III (Vps34), PUMA (Cell Signaling Technology), LC3, NOXA (Novus), p62/
SQSTM1 (Abnova), b-actin, and Tubulin (DM1A) (Sigma-Aldrich).
Expression Constructs, Small Interfering RNA, Small Hairpin RNA,
Transfection, and Transduction
pBabe-Puro-IMS-RP was provided by Dr. John Albeck. Retrovirus particles
were produced by cotransfecting GP2-293 cells (Clontech Laboratories)
pBbabe-Puro-IMS-RP with Vesicular Stomatitis Virus G protein (VSVG) using
TransIT-LT1 (Mirus). Media containing viral particles were collected at 48 hr
and at 72 hr posttransfection and stored at 80C. Cells were plated at
10,000–30,000 cells/well in a 6-well plate, 24 hr prior to transduction. For
IncuCyte experiments, HeLa cells were plated at 820 cells/well in a 48-well
plate, and transduction was performed to scale for single- and double-knock-
down experiments. HeLa cells stably expressing Intermembrane Space-Red
Fluorescent protein (HeLa-IMS-RP) were generated by puromycin selection
to produce single clones. HeLa-IMS-RP cells stably expressing pEGFP-LC3
or pmCherry-LC3 were generated by transfection with Trans-IT-LT1 and hy-
gromycin selection.
Small interfering RNA (siRNA) and shRNA knockdowns were performed
using SMARTpool:ON TARGET PLUS and pLKO.1 shRNA lentiviruses
(sequences are in Supplemental Experimental Procedures). After infection,
cells transduced with shRNA lentivirus were allowed to grow and passaged
only three times before being discarded to avoid selection for loss of
ATG gene knockdown-mediated inhibition of autophagy (Staskiewicz et al.,
2013).
Time-Lapse Video Microscopy and Image Analysis
Time-lapse movies were generated using a Zeiss Axiovert 100 fluorescence
microscope enclosed in an environmental chamber (Carl Zeiss) at 103, 323,
or 403 magnification. Images were captured with a Hamamatsu Orca CCD
camera every 4–6 min using Volocity imaging software (PerkinElmer). Cells
were grown in either 6-well plates or 24-well plates (Costar Incorporated and
MatTek). IMS-RP release was analyzed visually and by using Volocity software
to measure the timing of the drop in SD of the mean red fluorescence intensity
when the fluorescent signal changed from more punctate mitochondrial IMS-
RP fluorescence to diffuse cytoplasmic fluorescence after mitochondrial outer
membrane permeabilization. The area of each cell was determined using
Volocity software. Time-lapse movies in Figure 2A were generated using a
Nikon A1R-Si spectral imaging confocal microscope equipped with an envi-
ronmental chamber (Nikon) at 403 magnification. Images were taken every
4 min using ImageJ software. In Figure 4 and in Figure S3, quantitative live
cell imaging to assess long-term viability was performed using an IncuCyte
Zoom imaging system (Essen Biosciences). Images were obtained every
4 hr using a 103 objective. Live cell content was determined using the custom
parameters for measuring cell confluence and/or fluorescence. For fluores-
cence imaging of mixed cultures, HeLa cells expressing nuclear GFP or
mCherry were used expressing control or targeted shRNA lentiviruses.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.02.036.
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